AnitaD'SouzaMD

PubMed

• 2 citations
  Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody.
  Marc S Raab, Yael C Cohen, Fredrik Schjesvold, Kimberly Aardalen, Adwait Oka, Andrew Spencer, Martin Wermke, Anita D Souza, Jonathan L Kaufman, Anna Maria Cafro, Enriq...> ;Leukemia. 2023 Jun 1
• 2 citations
  A cross-sectional study of patient-reported outcomes and symptom burden using PROMIS and PRO-CTCAE measures in light chain amyloidosis.
  Anita D'Souza, Aniko Szabo, Idayat Akinola, Muriel Finkel, Kathryn E Flynn> ;Quality of Life Research. 2023 Jun 1
• Reply to E.R.S. Cliff et al.
  Anita D'Souza, Shaji Kumar> ;Journal of Clinical Oncology. 2023 Apr 1
• DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma.
  Anita D'Souza, Ruta Brazauskas, Bi Qing Teng, Grant Yun, Hannah Uttley, Jing Dong, Michael B Dwinell, Marcelo C Pasquini, Sergio Giralt, Heather Landau, Edward Stadtma...> ;Bone Marrow Transplantation. 2023 Mar 1
• 1 citations
  Exploring health behaviors and the feasibility of a lifestyle intervention for patients with multiple myeloma.
  Allen Hodge, Patricia Sheean, Paula O'Connor, Kiley Tyler, Abigail Kerschner, Alexis Williams, Kathleen Jensik, Alexis Visotcky, Anita D'Souza, Parameswaran Hari, Bino...> ;Supportive Care in Cancer. 2022 Dec 1
• 1 citations
  Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.
  Angela Dispenzieri, Jeffrey Zonder, James Hoffman, Sandra W Wong, Michaela Liedtke, Rafat Abonour, Anita D'Souza, Charlene Lee, Sarah Cote, Ravi Potluri, Eric Ammann, ...> ;Amyloid. 2023 Jun 1
• 3 citations
  Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic...
  Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, Corey S Cutler, Wael Saber, Stephanie J Lee, Brent R Logan, Bronwen E Shaw, Alyssa Gregory, Anita D'Souza, Betty K...> ;American Journal of Hematology. 2023 Feb 1
• 13 citations
  Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma.
  Aniko Szabo, Abhishek Janardan, Binod Dhakal, Saurabh Chhabra, Anita D'Souza, Meera Mohan, Hammons, L.> ;JAMA Network Open. 2022 Oct 3
• Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transp...
  Saurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, Fenlu Zhu, Xiaoying Tang, Mei-Jie Zhang, Robert Thompson, Sameem Abedin, Anita D'Souza, Binod Dhakal, William R D...> ;Transplantation and Cellular Therapy. 2022 Oct 1
• 5 citations
  Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
  Meera Mohan, Lisa E Rein, Nishanth Thalambedu, Yetunde Ogunsesan, Munawwar Hussain, Jaskirat Sethi, Fatima Khan, Sravani Gundarlapalli, Lakshmi Yarlagadda, Binod Dhaka...> ;American Journal of Hematology. 2022 Dec 1
• 98 citations
  Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.
  Costa, L., Chhabra, S., Medvedova, E., Dholaria, B., Schmidt, T., Godby, K., Silbermann, R., Dhakal, B., Bal, S., Giri, S., D'Souza, A., Hall, A., Hardwick, P., Omel, ...> ;Journal of Clinical Oncology. 2022 Sep 1
• 34 citations
  A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Mye...
  Anita D'Souza, Nina Shah, Cesar Rodriguez, Peter M Voorhees, Katja Weisel, Orlando F Bueno, Rajvineeth K Pothacamury, Kevin J Freise, Susan Yue, Jeremy A Ross, Akshant...> ;Journal of Clinical Oncology. 2022 Nov 1
• 2 citations
  Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies.
  Meera Mohan, Sneha Nagavally, Nirav N Shah N, Laura Michaelis, Saurabh Chhabra, Anita D Souza, Sameem Abedin, Lyndsey Runaas, Guru Subramanian Guru Murthy, Walter Long...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Jul 1
• 3 citations
  Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
  Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal...> ;American Journal of Hematology. 2022 Jul 1
• Important questions for the malignant hematologist to consider when designing or evaluating a study with patient-reported outcome measures (PROMs).
  Amaris K Balitsky, Anita D'Souza, Mark N Levine> ;European Journal of Haematology. 2022 Jul 1
• 3 citations
  Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study.
  Christopher Staffi Buradagunta, Zhuping Garacci, Anita D'Souza, Binod Dhakal, Sumana Devata, Siegfried Janz, Aaron P Thrift, Parameswaran Hari, Melinda Stolley, Jing Dong> ;Blood Cancer Journal. 2022 May 25
• 11 citations
  Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
  Anita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, Marcelo C Pasquini, Parameswaran Hari, Asad Bashey, Natalie Callander, Steven Devine, Yvonne Efebera, Siddhartha G...> ;American Journal of Hematology. 2023 Jan 1
• MGIP, MGUS, and the PROMISE of meaning in small things.
  Anita D'Souza, Luciano J Costa> ;The Lancet. Haematology. 2022 May 1
• 5 citations
  Nutrition perceptions, needs and practices among patients with plasma cell disorders.
  Maria A Malik, Nathan W Sweeney, Mohammad Jafri, Andriy Derkach, Cynthia Chmielewski, Peter A Adintori, Sham Mailankody, Neha Korde, Carlyn R Tan, Hani Hassoun, Malin ...> ;Blood Cancer Journal. 2022 Apr 20
• 33 citations
  Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients.
  Muhammad Bilal Abid, Micah Rubin, Nathan Ledeboer, Aniko Szabo, Walter Longo, Meera Mohan, Nirav N Shah, Timothy S Fenske, Sameem Abedin, Lyndsey Runaas, Anita D'Souza...> ;Cancer Cell. 2022 Apr 11
• 1 citations
  Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol.
  Alexander K Johnson, Ellen L Lorimer, Aniko Szabo, Ruizhe Wu, Nirav N Shah, Anita D'Souza, Saurabh Chhabra, Mehdi Hamadani, Binod Dhakal, Parameswaran Hari, Sridhar Ra...> ;The Yale Journal of Biology and Medicine. 2022 Mar 1
• 22 citations
  Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study.
  Jing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, Anita D'Souza, Meera Mohan, Ashley Cunningham, Siegfried Janz, Binod Dhakal, Aaron P Thrift, Parameswaran Hari> ;Blood Cancer Journal. 2022 Feb 24
• 5 citations
  Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study.
  Hira Mian, Rinku Sutradhar, Gregory R Pond, Branavan Sivapathasundaram, Jonathan Sussman, Amaris Balitsky, Anita D'Souza, Tanya M Wildes, Hsien Seow> ;Blood Cancer Journal. 2022 Jan 27
• 2 citations
  A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients.
  Carlyn Tan, Noel Estrada-Merly, Heather Landau, Lazaros J. Lekakis, Rahul Banerjee, Hira S. Mian, Saad Z. Usmani, Amr Hanbali, Hillard M. Lazarus, Robert A. Kyle, Bhag...> ;Bone Marrow Transplantation. 2021 Nov 20
• 10 citations
  Title: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell...
  Surbhi Sidana, Shaji Kumar, Raphael Fraser, Noel Estrada-Merly, Sergio Giralt, Vaibhav Agrawal, Larry D. Anderson, Mahmoud Aljurf, Rahul Banerjee, Asad Bashey, Minoo B...> ;Transplantation and Cellular Therapy. 2021 Nov 12
• Join now to see all

Abstracts/Posters

• Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Mu...
  Anita D'Souza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation
  Anita D'Souza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)
  Anita D'Souza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma
  Anita D'Souza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Outcomes of Hip Arthroplasty in Sickle Cell Disease: A 20 Year Retrospective Review 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018